Introduction:

Bilirubin Meter Market was valued at US$ 299.1 million in 2024 and is projected to grow at a CAGR of 7.2% to reach US$ 564.3 million by 2034.

Bilirubin meter market involves manufacturers and distributors of instruments for determining the body's bilirubin levels. The natural disintegration of red blood cells produces the yellow pigment known as bilirubin. Normally, the liver eliminates it from the body and excretes it in bile.

Blood bilirubin levels can be measured easily with bilirubin meters. This is especially helpful for neonatal care, as it can be difficult or stressful for newborns to have their blood drawn for laboratory tests. Bilirubin levels may be quickly and precisely measured, which makes therapy and management possible in a timely manner, particularly for newborns. Also, when used for point-of-care testing, bilirubin meters frequently enable medical personnel’s to get rapid results at the patient’s bedside. This enables prompt decision-making and suitable treatment for individuals with high bilirubin levels.

The need for precise and efficient bilirubin meters is being driven by growing awareness of the need of treating newborn jaundice as soon as possible. Bilirubin levels can now be measured non-invasively, eliminating the need for uncomfortable blood tests and increasing patient comfort. One example of this technology innovation in bilirubin meters is the creation of transcutaneous bilirubinometers. Bilirubin meters are now more frequently used in clinics, hospitals, and neonatal care units as a result of this.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Bilirubin Meter Market Key Drivers:

• The occurrence of jaundice among newborns  

The occurrence of jaundice in infants is a common illness and a major factor driving the market for bilirubin meters. In order to avoid issues linked to increased bilirubin, these devices are crucial for monitoring bilirubin levels in neonates. Wider use of bilirubin meters for early diagnosis and management is a result of parents' and healthcare professionals' growing knowledge of neonatal jaundice and its possible implications.

• Advancements in Technology  

More precise and user-friendly bilirubin meters have been developed as a result of ongoing technological breakthroughs. The accuracy and dependability of bilirubin readings are improved by technological advancements including the use of LED light sources and complex optical sensors. Improvements in bilirubin meter technology, such as increased connectivity, portability, and accuracy, increase their usefulness and user-friendliness and encourage wider implementation.

Bilirubin Meter Market Restrains:

• High cost of investment

Particularly in areas with tight healthcare budgets, the expense of bilirubin meters may be a deterrent for its growth. Purchasing expensive medical equipment’s may be difficult for many healthcare facilities, particularly for those in underdeveloped nations. Financial resource conflicts are a common occurrence for healthcare facilities. Additionally, these meters can be expensive initially, competing with other necessary expenditures like staff training, facility expansion, or up gradation of medical equipment’s. Healthcare administrators may therefore face a problem with prioritizing.

• Absence of Skilled Workforce

Advanced bilirubin meters may need to be operated and maintained by skilled workers, which might be difficult in areas with inadequate healthcare infrastructure. Certain advanced bilirubin meters may have features that need specialized training and experience to use and maintain properly. These functions could go unused, can produce erroneous readings, or harm equipment if handled by untrained workers.

Bilirubin Meter Market is segmented based on Type, Application, and region.

Type Insights

• Bench-top: Bench-top involves conventional laboratory instruments with excellent precision but has limited mobility. They work well in larger medical centers and hospitals where testing is done regularly and consistently.
• Transcutaneous: Transcutaneous meters is a dominating segment in this sector as they are portable and non-invasive in nature, and therefore very effective for home care for newborns and infants. It is anticipated to develop more quickly due to its ease of use and the rising need for non-invasive liver disease diagnostics.

Application Insights

• Hospital: Hospitals hold a major revenue share for this sector and are the primary users of these meters because of the volume of patients that visit the facility and the established procedures which are followed every day. Transcutaneous meters are increasingly preferred for use with neonates and outpatients.
• Medical Center: Medical Centers are expanding due to use of these meters in ambulatory surgical centers and clinics, who are looking for less invasive and more affordable solutions. For flexibility in point-of-care testing, medical centers may use portable transcutaneous bilirubin meters, depending on their size and services offered.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Bilirubin Meter Market Regional Insights

• North America market is estimated to witness fastest revenue share, due to the high adoption of cutting-edge medical technologies and the existence of reputable healthcare facilities in the region. The growth is also aided by the government's execution of programs to lower newborn death rates and the growing emphasis on neonatal care. Additionally, the accuracy and efficiency of these meters are anticipated to be improved by the incorporation of machine learning algorithms and artificial intelligence (AI) in these meters, which will further propel market expansion in this area.
• Asia Pacific market is estimated to witness a significantly high revenue share over the forecast period, due to growing rates of newborn jaundice, improved healthcare systems in developing nations and growing public knowledge of early detection and treatment, are all factors contributing to this region's growth. Additionally, the Asia-Pacific market is growing due to the development of the e-commerce sector and the accessibility of reasonably priced bilirubin meters via online platforms.
• Europe market is anticipated to have a moderate rate of growth over the projection period. The expansion in this area might be linked to the rising understanding of the significance of prompt detection and treatment of newborn jaundice. Furthermore, the growing emphasis on research and development endeavors within the newborn care domain is anticipated to encourage the market's revenue expansion in Europe. It is anticipated that the demand for bilirubin meters in the area will be driven by the introduction of non-invasive diagnostic instruments like transcutaneous bilirubinometers.
• Latin America market is an emerging region for these meters and is impacted by raising awareness and building up of the healthcare system. There is a need for both kinds of bilirubin meters because medical centers come in different sizes and therefore with different requirements.
• Middle East & Africa market is in its developmental stages and is steadily expanding, due to the advancement in healthcare system and infrastructure. In established facilities, bench-top meters are frequently utilized, although transcutaneous meters are becoming more and more popular for dispersed testing.

Report Scope:

Attribute	Details
Market Size 2024	US$ 299.1 million
Projected Market Size 2034	US$ 564.3 million
CAGR Growth Rate	7.2%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Million & CAGR from 2024 to 2034
Market Segmentation	By Type - Bench-top, and Transcutaneous By Application - Hospital, and Medical Center
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Bilirubin Meter Market report based on Type, Application and region:

Bilirubin Meter Market, By Type:

• Bench-top
• Transcutaneous

Bilirubin Meter Market, By Application:

• Hospital
• Medical Center

Bilirubin Meter Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Bilirubin Meter Market includes, Delta Medical, Advance Medical, Drager Ltd., GineVRi Inc., Natus Medical, MBR Corp, F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Mennen Medical Ltd, and Siemens Healthineers AG.

Recent Development:

• In June 2022, University of Ghana and University College London collaborated to develop the neoSCB, a smartphone app that can precisely detect jaundice in infants by looking at them. It has been verified in a clinical trial conducted in Ghana, where it was demonstrated to be just as accurate as conventional techniques for determining a newborn's bilirubin levels.

• Delta Medical*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Advance Medical
• Drager Ltd.
• GineVRi Inc.
• Natus Medical
• MBR Corp
• F. Hoffmann-La Roche Ltd.
• Koninklijke Philips N.V.
• Mennen Medical Ltd
• Siemens Healthineers AG

“*” marked represents similar segmentation in other categories in the respective section.

Research Objective and Assumption

• Preface
• Research Objectives
• Study Scope
• Years Considered for the study
• Assumptions
• Abbreviations

Research Methodology

• Research data
• Primary Data
  • Primary Interviews
  • Primary Breakdown
  • Key data from Primary Sources
  • Key Thickness Insights
• Secondary Data
  • Major Secondary Sources
  • Secondary Sources
• Market Estimation
• Top-Down Approach
  • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
• Bottom-Up Approach
  • Approach for estimating market share by Bottom-up Analysis (Demand Side)
• Market Breakdown and Data Triangulation
• Research Assumptions

Market Preview

• Executive Summary
• Key Findings—Global Outlook for medical carts Strategies
  • Key Questions this Study will Answer
  • Market Snippet, By Type
  • Market Snippet, By Application
  • Market Snippet, By Region
• Opportunity Map Analysis
• Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restrains
  • Market Opportunities
  • Market Trends
• DR Impact Analysis
• PEST Analysis
• Porter’s Five Forces Analysis
• Opportunity Orbit
• Market Investment Feasibility Index
• Macroeconomic Factor Analysis

Market Segmentation, By Type, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Bench-top
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Transcutaneous
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Application, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Hospital
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Medical Center
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • UK
    • France
    • Germany
    • Russia
    • Italy
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

Competitive Landscape

• Heat Map Analysis
• Market Presence and Specificity Analysis

Company Profiles

• Delta Medical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Advance Medical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Drager Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• GineVRi Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Natus Medical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• MBR Corp
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact